Skip to main content
. 2013 Sep 10;2013:bcr2013200867. doi: 10.1136/bcr-2013-200867

Figure 3.

Figure 3

(A) Contrast-enhanced brain CT before initiating crizotinib showing masses with ring enhancement in left frontal lobe and cerebellar hemisphere, and multiple tiny nodules. (B) Contrast-enhanced brain CT obtained on 17 weeks after initiating crizotinib showing all metastatic lesions decreasing in size.